REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.85
+0.17 (2.54%)
Oct 26, 2026, 10:00 AM EDT - Market open
REGENXBIO Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 452 | 729 | 383 | 790 | 982 | 1,399 | |
Market Cap Growth | -26.57% | 90.34% | -51.50% | -19.58% | -29.79% | -17.58% |
Enterprise Value | 597 | 695 | 250 | 622 | 601 | 1,130 |
Last Close Price | 6.68 | 14.40 | 7.73 | 17.95 | 22.68 | 32.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 10.94 |
Forward PE | - | 35.95 | 54.68 | 54.68 | 54.68 | 76.17 |
PS Ratio | 2.53 | 4.28 | 4.60 | 8.75 | 8.71 | 2.97 |
PB Ratio | 5.04 | 7.10 | 1.48 | 2.53 | 1.90 | 1.83 |
P/TBV Ratio | 6.14 | 7.10 | 1.48 | 2.53 | 1.90 | 1.83 |
P/FCF Ratio | - | - | - | - | - | 10.38 |
P/OCF Ratio | - | - | - | - | - | 6.39 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.36 | 4.08 | 3.00 | 6.89 | 5.33 | 2.40 |
EV/EBITDA Ratio | - | - | - | - | - | 6.67 |
EV/EBIT Ratio | - | - | - | - | - | 7.06 |
EV/FCF Ratio | - | - | - | - | - | 8.39 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 3.49 | 2.54 | 0.55 | 0.59 | 0.45 | 0.34 |
Debt / EBITDA Ratio | - | - | - | - | - | 1.42 |
Debt / FCF Ratio | - | - | - | - | - | 1.92 |
Net Debt / Equity Ratio | 2.02 | 0.19 | -0.40 | -0.42 | -0.64 | -0.77 |
Net Debt / EBITDA Ratio | -0.97 | -0.13 | 0.48 | 0.53 | 1.37 | -3.49 |
Net Debt / FCF Ratio | -0.58 | -0.16 | 0.59 | 0.57 | 1.40 | -4.39 |
Asset Turnover | 0.36 | 0.37 | 0.16 | 0.13 | 0.12 | 0.52 |
Quick Ratio | 2.70 | 2.27 | 2.59 | 2.45 | 3.08 | 3.73 |
Current Ratio | 2.86 | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 |
Return on Equity (ROE) | -137.63% | -107.00% | -79.49% | -63.65% | -43.78% | 22.39% |
Return on Assets (ROA) | -21.20% | -21.93% | -27.79% | -23.49% | -16.39% | 10.97% |
Return on Invested Capital (ROIC) | -97.79% | -107.51% | -119.66% | -87.59% | -53.83% | 39.52% |
Return on Capital Employed (ROCE) | -54.00% | -48.10% | -63.70% | -59.60% | -36.30% | 16.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -54.97% | -26.60% | -59.30% | -33.37% | -28.55% | 9.14% |
FCF Yield | -56.62% | -17.34% | -45.84% | -28.92% | -24.26% | 9.63% |
Buyback Yield / Dilution | -2.03% | -4.17% | -13.21% | -1.35% | 1.73% | -17.79% |